Order Article Reprints

Kirkegaard-Biosca C, del Barrio-Tofiño E, Villamarín M, Larrosa N, Campany D, González-López JJ, Ferrer R, Viñado B, Doménech L, Sellarès-Nadal J, et al. Correction: Kirkegaard-Biosca et al. Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria. Antibiotics 2024, 13, 874. Antibiotics. 2025; 14(1):4. https://doi.org/10.3390/antibiotics14010004

Kirkegaard-Biosca, Cristina, Ester del Barrio-Tofiño, Miguel Villamarín, Nieves Larrosa, David Campany, Juan José González-López, Ricard Ferrer, Belén Viñado, Laura Doménech, Julia Sellarès-Nadal, and et al. 2025. "Correction: Kirkegaard-Biosca et al. Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria. Antibiotics 2024, 13, 874" Antibiotics 14, no. 1: 4. https://doi.org/10.3390/antibiotics14010004

Kirkegaard-Biosca, C., del Barrio-Tofiño, E., Villamarín, M., Larrosa, N., Campany, D., González-López, J. J., Ferrer, R., Viñado, B., Doménech, L., Sellarès-Nadal, J., Escolà-Vergé, L., Fernández-Hidalgo, N., & Los-Arcos, I. (2025). Correction: Kirkegaard-Biosca et al. Cefiderocol for the Treatment of Infections by VIM-Type-Producing Gram-Negative Bacteria. Antibiotics 2024, 13, 874. Antibiotics, 14(1), 4. https://doi.org/10.3390/antibiotics14010004